Magazine Article | October 1, 2020

Changing How We Target Rare Diseases

Source: Life Science Leader

By Lindsey Sutton & Melissa Goetz

When we founded the FCS Foundation in 2016, one of our main goals was to help more people learn about and understand the impact of familial chylomicronemia syndrome (FCS), a rare disorder where the body is unable to break down triglycerides (fats) in the body. FCS affects only about one in a million people, and so most people, including many clinicians, are not familiar with it. As we worked to build awareness, we also quickly noticed that even leaders in industry and at the FDA had a limited understanding of this disease.

VIEW THE MAGAZINE ARTICLE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Life Science Leader? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
I'm interested in newsletter subscriptions.
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: